Optimizing the delivery of chemotherapy in the setting of immunotherapy in a preclinical glioblastoma model

Benzer Materyaller

• Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
  Yazar:: Garzon-Muvdi, Tomas, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
  Yazar:: Mathios, Dimitrios, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• IT-21 PD-1 BLOCKADE SHOWS SYNERGISTIC SURVIVAL, ANTI-TUMOR IMMUNE RESPONSE AND LONG-TERM MEMORY WITH INTERSTITIAL BUT NOT SYSTEMIC CHEMOTHERAPY: STUDY IN A MURINE GLIOBLASTOMA MODEL
  Yazar:: Mathios, Dimitrios, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• IMPS-20 COMBINATION THERAPY WITH ANTI-PD-1, ANTI-TIM-3, AND FOCAL RADIATION RESULTS IN REGRESSION OF MURINE GLIOMAS
  Yazar:: Kim, Jennifer E., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system
  Yazar:: Maxwell, Russell, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)